Literature DB >> 19282467

Effectiveness of organised versus opportunistic mammography screening.

J-L Bulliard1, C Ducros, C Jemelin, B Arzel, G Fioretta, F Levi.   

Abstract

BACKGROUND: Detailed comparison of effectiveness between organised and opportunistic mammography screening operating in the same country has seldom been carried out. PATIENTS AND METHODS: Prognostic indicators, as defined in the European Guidelines, were used to evaluate screening effectiveness in Switzerland. Matching of screening programmes' records with population-based cancer registries enabled to compare indicators of effectiveness by screening and detection modality (organised versus opportunistic screening, unscreened, interval cancers). Comparisons of prognostic profile were also drawn with two Swiss regions uncovered by service screening of low and high prevalence of opportunistic screening, respectively.
RESULTS: Opportunistic and organised screening yielded overall little difference in prognostic profile. Both screening types led to substantial stage shifting. Breast cancer prognostic indicators were systematically more favourable in Swiss regions covered by a programme. In regions without a screening programme, the higher the prevalence of opportunistic screening, the better was the prognostic profile.
CONCLUSIONS: Organised screening appeared as effective as opportunistic screening. Mammography screening has strongly influenced the stage distribution of breast cancer in Switzerland, and a favourable impact on mortality is anticipated. Extension of organised mammography screening to the whole of Switzerland can be expected to further improve breast cancer prognosis in a cost-effective way.

Entities:  

Mesh:

Year:  2009        PMID: 19282467     DOI: 10.1093/annonc/mdn770

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  11 in total

1.  Biennial screening mammography: How many women ask for more? Estimate of the interval mammogram rate in an organised population-based screening programme.

Authors:  Luca Alessandro Carbonaro; Sighelgaita Sonia Rizzo; Simone Schiaffino; Anna Pisani Mainini; Nicole Berger; Rubina Manuela Trimboli; Francesco Sardanelli
Journal:  Radiol Med       Date:  2020-06-23       Impact factor: 3.469

2.  Recent prediagnostic aspirin use, lymph node involvement, and 5-year mortality in women with stage I-III breast cancer: a nationwide population-based cohort study.

Authors:  Thomas I Barron; Evelyn M Flahavan; Linda Sharp; Kathleen Bennett; Kala Visvanathan
Journal:  Cancer Res       Date:  2014-08-01       Impact factor: 12.701

3.  Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme.

Authors:  Ondrej Majek; Jan Danes; Miroslava Skovajsova; Helena Bartonkova; Lucie Buresova; Daniel Klimes; Petr Brabec; Pavel Kozeny; Ladislav Dusek
Journal:  BMC Public Health       Date:  2011-05-10       Impact factor: 3.295

4.  Introduction of organised mammography screening in Tyrol: results following first year of complete rollout.

Authors:  Willi Oberaigner; Martin Daniaux; Sabine Geiger-Gritsch; Rudolf Knapp; Uwe Siebert; Wolfgang Buchberger
Journal:  BMC Public Health       Date:  2011-08-30       Impact factor: 3.295

5.  Opportunistic mammography screening provides effective detection rates in a limited resource healthcare system.

Authors:  Yew-Ching Teh; Gie-Hooi Tan; Nur Aishah Taib; Kartini Rahmat; Caroline Judy Westerhout; Farhana Fadzli; Mee-Hoong See; Suniza Jamaris; Cheng-Har Yip
Journal:  BMC Cancer       Date:  2015-05-15       Impact factor: 4.430

6.  Performance of a subsidised mammographic screening programme in Malaysia, a middle-income Asian country.

Authors:  Marianne Lee; Shivaani Mariapun; Nadia Rajaram; Soo-Hwang Teo; Cheng-Har Yip
Journal:  BMC Public Health       Date:  2017-01-28       Impact factor: 3.295

7.  Effect of an organised screening program on socioeconomic inequalities in mammography practice, knowledge and attitudes.

Authors:  A Relecom; B Arzel; T Perneger
Journal:  Int J Equity Health       Date:  2018-07-03

8.  Assessment of breast cancer opportunistic screening by clinical-pathological indicators: a population-based study.

Authors:  A Bordoni; N M Probst-Hensch; L Mazzucchelli; A Spitale
Journal:  Br J Cancer       Date:  2009-10-27       Impact factor: 7.640

9.  Assessment of HER2 status in breast cancer: overall positivity rate and accuracy by fluorescence in situ hybridization and immunohistochemistry in a single institution over 12 years: a quality control study.

Authors:  Zsuzsanna Varga; Aurelia Noske; Constanze Ramach; Barbara Padberg; Holger Moch
Journal:  BMC Cancer       Date:  2013-12-30       Impact factor: 4.430

10.  Increased breast cancer screening and downstaging in Colombian women: A randomized trial of opportunistic breast-screening.

Authors:  Raúl Murillo; Sandra Díaz; Fernando Perry; César Poveda; Marion Piñeros; Oswaldo Sánchez; Lina Buitrago; Oscar Gamboa; Teófilo Lozano; Hsiang Yu; Ching-Yun Wang; Catherine Duggan; David B Thomas; Benjamin O Anderson
Journal:  Int J Cancer       Date:  2015-09-02       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.